Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (15)
  • Open Access


    Prediction of Suitable Candidates for COVID-19 Vaccination

    R. Sujatha1, B. Venkata Siva Krishna1, Jyotir Moy Chatterjee2, P. Rahul Naidu1, NZ Jhanjhi3,*, Challa Charita1, Eza Nerin Mariya1, Mohammed Baz4

    Intelligent Automation & Soft Computing, Vol.32, No.1, pp. 525-541, 2022, DOI:10.32604/iasc.2022.021216

    Abstract In the current times, COVID-19 has taken a handful of people’s lives. So, vaccination is crucial for everyone to avoid the spread of the disease. However, not every vaccine will be perfect or will get success for everyone. In the present work, we have analyzed the data from the Vaccine Adverse Event Reporting System and understood that the vaccines given to the people might or might not work considering certain demographic factors like age, gender, and multiple other variables like the state of living, etc. This variable is considered because it explains the unmentioned variables like their food habits and… More >

  • Open Access


    Improving Routine Immunization Coverage Through Optimally Designed Predictive Models

    Fareeha Sameen1, Abdul Momin Kazi2, Majida Kazmi1,*, Munir A Abbasi3, Saad Ahmed Qazi1,4, Lampros K Stergioulas3,5

    CMC-Computers, Materials & Continua, Vol.70, No.1, pp. 375-395, 2022, DOI:10.32604/cmc.2022.019167

    Abstract Routine immunization (RI) of children is the most effective and timely public health intervention for decreasing child mortality rates around the globe. Pakistan being a low-and-middle-income-country (LMIC) has one of the highest child mortality rates in the world occurring mainly due to vaccine-preventable diseases (VPDs). For improving RI coverage, a critical need is to establish potential RI defaulters at an early stage, so that appropriate interventions can be targeted towards such population who are identified to be at risk of missing on their scheduled vaccine uptakes. In this paper, a machine learning (ML) based predictive model has been proposed to… More >

  • Open Access


    Empirical Assessment of Bacillus Calmette-Guérin Vaccine to Combat COVID-19

    Nikita Jain1, Vedika Gupta1,*, Chinmay Chakraborty2, Agam Madan1, Deepali Virmani3, Lorenzo Salas-Morera4, Laura Garcia-Hernandez4

    CMC-Computers, Materials & Continua, Vol.70, No.1, pp. 213-231, 2022, DOI:10.32604/cmc.2022.016424

    Abstract COVID-19 has become one of the critical health issues globally, which surfaced first in latter part of the year 2019. It is the topmost concern for many nations’ governments as the contagious virus started mushrooming over adjacent regions of infected areas. In 1980, a vaccine called Bacillus Calmette-Guérin (BCG) was introduced for preventing tuberculosis and lung cancer. Countries that have made the BCG vaccine mandatory have witnessed a lesser COVID-19 fatality rate than the countries that have not made it compulsory. This paper’s initial research shows that the countries with a long-term compulsory BCG vaccination system are less affected by… More >

  • Open Access


    COVID-19 Vaccine Priority Access for Adults and Children with Congenital Heart Disease: A Statement of the Italian Society of Pediatric Cardiology

    Gabriele Egidy Assenza1, Biagio Castaldi2,*, Serena Flocco3, Giovanni Battista Luciani4, Giovanni Meliota5, Gabriele Rinelli6, Ugo Vairo5, Silvia Favilli7, Board of the Italian Society of Pediatric Cardiology

    Congenital Heart Disease, Vol.16, No.5, pp. 427-431, 2021, DOI:10.32604/CHD.2021.016713

    Abstract COVID-19 pandemic continues to strike across the world with increasing number of infected patients, severe morbidity and mortality, social life and economy disruption. Universal access to vaccine prophylaxis will be pivotal in controlling this infection and providing individual level protection. However, mismatch between vaccine request and vaccine availability, as well as constraints in logistics of vaccine campaign is creating a transition phase of progressive but still incomplete inclusion of group of individuals in the vaccination process. Selected patients living with chronic and multisystemic disease may present increased propensity of adverse outcome, should Sars-Cov-2 infection develop. In these patients, expedite access… More >

  • Open Access


    Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving


    BIOCELL, Vol.44, No.2, pp. 127-135, 2020, DOI:10.32604/biocell.2020.010018

    Abstract From late December 2019 a new human-adapted coronavirus, SARS-CoV-2, was observed and isolated in clustered patients in Wuhan, China. It has been proved to be able to transmit human-to-human and cause pneumonia, leading to about 2% fatality. Its genome characteristics, immune responses and related potential treatments, such as chemical drugs, serum transfusion and vaccines including DNA vaccines, are discussed in this review for a brief summary. More >

Displaying 11-20 on page 2 of 15. Per Page